# FDA Orange Book License Terms

License details for FDA Orange Book (Approved Drug Products with Therapeutic Equivalence Evaluations) data usage.

---

## Quick Reference

| Property | Value |
|----------|-------|
| License | Public Domain (US Government Work) |
| SPDX Identifier | CC0-1.0 |
| Commercial Use | Yes |
| Attribution Required | No |
| Redistribution | Yes |

---

## Summary

The FDA Orange Book is a US government work produced by the Food and Drug Administration. As such, it is in the public domain and freely available for any use, including commercial applications, without restriction or licensing fees.

---

## Permissions

What you CAN do with this data:

- Use for any purpose including commercial applications
- Redistribute without restriction
- Create commercial pharmaceutical intelligence products
- Integrate into patent and regulatory databases
- Build generic drug development planning tools

---

## Restrictions

There are no restrictions on use of this public domain data. However:

- Data reflects FDA determinations at time of publication
- Users should verify currency with official FDA sources
- Therapeutic equivalence determinations may be updated

---

## Attribution Template

While not required, attribution is recommended:

```
FDA Orange Book data from the U.S. Food and Drug Administration
(https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files).
```

### Citation

```
FDA. Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book).
https://www.fda.gov/drugs/development-approval-process-drugs/orange-book-preface
```

---

## Contact

- Web Search: https://www.accessdata.fda.gov/scripts/cder/ob/
- Data Files: https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files

---

## Source Documents

- [Orange Book Homepage](https://www.fda.gov/drugs/development-approval-process-drugs/orange-book-preface)
- [FDA Terms of Use](https://www.fda.gov/about-fda/website-policies)
